A serum metabolomics study on the intervention of nonalcoholic fatty liver disease by equicaloric low-carbohydrate high-protein diet combined with aerobic exercise

Meiying LI; Wanli JI; Wangzhenzu LIU; Tao WANG; Shengnan DU; Jingjing GAO; Yuanye JIANG; Cheng HU

doi:10.3969/j.issn.1001-5256.2021.11.023

Volume 37 Issue 11

Nov. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(11): 2605-2610

PDF( 4093 KB)

A serum metabolomics study on the intervention of nonalcoholic fatty liver disease by equicaloric low-carbohydrate high-protein diet combined with aerobic exercise

DOI: 10.3969/j.issn.1001-5256.2021.11.023

Meiying LI^1a,
Wanli JI²,
Wangzhenzu LIU^3a,
Tao WANG^1b,
Shengnan DU^1b,
Jingjing GAO^1b,
Yuanye JIANG^{1b
,
,},
Cheng HU^{3b
,
,}

1a.
Health Management Center, Putuo District Central Hospital, Shanghai 200062, China
1b.
Department of Gastroenrology, Putuo District Central Hospital, Shanghai 200062, China
2.
College of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China
3a.
School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
3b.
Science and Technology Experimental Center, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China

Research funding:

National Natural Science Foundation of China (81703879);

Shanghai Municipal Commission of Health and Family Planning General Project for Clinical Research of Health Industry (201840377);

Shanghai Municipal Commission of Health and Family Planning General Project for Clinical Research of Health Industry (201940449);

Putuo District of Shanghai Science And Technology Commission Research Project (ptkwws201813);

Reserve Excellent TCM Talents Project of Shanghai University of Traditional Chinese Medicine (20D-RC-02)

Received Date: 2021-04-01
Accepted Date: 2021-05-06
Published Date: 2021-11-20

Abstract

Abstract

Objective To collect the serum samples of patients with nonalcoholic fatty liver disease (NAFLD), and to investigate the changes in serum metabolic biomarkers before and after lifestyle intervention. Methods A total of 23 patients who were diagnosed with NAFLD in Department of Gastroenterology and Inpatient Department, Putuo District Central Hospital of Shanghai, from January 2019 to January 2020 were enrolled, and all patients received the intervention with aerobic exercise and equicaloric low-carbohydrate high-protein diet. A total of 13 healthy volunteers who underwent physical examination in Physical Examination Center were enrolled as control group. For the patients with NAFLD, basic information was collected before and after intervention, blood samples were collected twice to measure liver function, blood glucose, and blood lipids, and part of serum was used for serum metabolomics analysis. The serum samples were analyzed by ultra-performance liquid chromatography/tandem high-resolution mass spectrometry. The data collected were processed in Compound Discover, and then principal component analysis (PCA) and orthogonal partial least squares discriminant analysis were used to establish the profile of differentially expressed blood metabolites between patients and healthy people and perform the enrichment analysis of differentially expressed metabolic pathways. The independent samples t-test was used for comparison of normally distributed continuous data between two groups, and the Wilcoxon non-parametric test was used for comparison of non-normally distributed continuous data between two groups. Results After lifestyle intervention, the patients had significant reductions in body mass index (P < 0.01), body weight (P < 0.01), and serum biochemical parameters alkaline phosphatase, albumin, gamma-glutamyl transpeptidase, and alanine aminotransferase (all P < 0.05), as well as a significant reduction in total protein (P < 0.01), while there were no significant improvements in cholinesterase, aspartate aminotransferase, and glucose. As for the four items for blood lipids, there was a significant reduction in triglyceride (P < 0.01), while there were no significant improvements in high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and total cholesterol. The metabolomics analysis showed that 33 serum metabolites changed significantly after lifestyle intervention. In addition, PCA results showed that after intervention, the level of metabolites in patients tended to be normal. The signaling pathway analysis showed that exercise and diet mainly affected the pathways of bile acid, unsaturated fatty acid synthesis, and phenylalanine metabolism. Conclusion Lifestyle intervention can achieve varying degrees of reduction in the body weight of patients with NAFLD, improve serum biochemical parameters, and regulate the abnormal metabolic pathway in patients with NAFLD, which has important clinical value and significance for guiding clinicians to formulate reasonable diet and exercise strategies for patients with NAFLD and prevent the progression of NAFLD.

FullText(HTML)

References(23)

References

[1]	DIEHL AM, DAY C. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis[J]. N Engl J Med, 2017, 377(21): 2063-2072. DOI: 10.1056/NEJMra1503519.
[2]	GAO JJ, WANG T, JIANG YY, et al. Metabonomics and traditional Chinese medicine syndrome of nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2020, 36(8): 1880-1882. DOI: 10.3969/j.issn.1001-5256.2020.08.044. 高静静, 汪涛, 蒋元烨, 等. 非酒精性脂肪性肝病代谢组学与中医证候[J]. 临床肝胆病杂志, 2020, 36(8): 1880-1882. DOI: 10.3969/j.issn.1001-5256.2020.08.044.
[3]	ANGELICO F, DEL BEN M, CONTI R, et al. Non-alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases[J]. J Gastroenterol Hepatol, 2003, 18(5): 588-594. DOI: 10.1046/j.1440-1746.2003.02958.x.
[4]	YANG CQ, SHU L, WANG S, et al. Dietary patterns modulate the risk of non-alcoholic fatty liver disease in chinese adults[J]. Nutrients, 2015, 7(6): 4778-4791. DOI: 10.3390/nu7064778.
[5]	BARSHOP NJ, SIRLIN CB, SCHWIMMER JB, et al. Review article: Epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease[J]. Aliment Pharmacol Ther, 2008, 28(1): 13-24. DOI: 10.1111/j.1365-2036.2008.03703.x.
[6]	MARDINOGLU A, WU H, BJORNSON E, et al. An integrated understanding of the rapid metabolic benefits of a carbohydrate-restricted diet on hepatic steatosis in humans[J]. Cell Metab, 2018, 27(3): 559-571. e5. DOI: 10.1016/j.cmet.2018.01.005.
[7]	JIMBA S, NAKAGAMI T, TAKAHASHI M, et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults[J]. Diabet Med, 2005, 22(9): 1141-1145. DOI: 10.1111/j.1464-5491.2005.01582.x.
[8]	FRIIS-LIBY I, ALDENBORG F, JERLSTAD P, et al. High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease[J]. Scand J Gastroenterol, 2004, 39(9): 864-869. DOI: 10.1080/00365520410006431.
[9]	HUANG W, KONG D. The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD[J]. Biomed Pharmacother, 2021, 135: 111235. DOI: 10.1016/j.biopha.2021.111235.
[10]	MA X, GU HT, ZHAO Y, et al. Serum metabolomics study on nonalcoholic fatty liver disease with liver damage of different syndromes[J]. China J Tradit Chin Med Pharma, 2017, 32(3): 1246-1250. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201703103.htm 马欣, 顾宏图, 赵瑜, 等. 不同证候的非酒精性脂肪肝合并肝损伤患者的血清代谢组学分析[J]. 中华中医药杂志, 2017, 32(3): 1246-1250. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201703103.htm
[11]	LIN L, YAN H, CHEN J, et al. Application of metabolomics in viral pneumonia treatment with traditional Chinese medicine[J]. Chin Med, 2019, 14: 8. DOI: 10.1186/s13020-019-0229-x.
[12]	Group of Fatty Liver and Alcoholic Liver Diseases, Society of Hepatology, Chinese Medical Association. Guidelines for Management of non-alcoholic fatty liver disease[J]. J Clin Hepatol, 2010, 26(2): 120-124. http://lcgdbzz.org/cn/article/doi/1001-5256%20(2010)%2002-0120-05 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南[J]. 临床肝胆病杂志, 2010, 26(2): 120-124. http://lcgdbzz.org/cn/article/doi/1001-5256%20(2010)%2002-0120-05
[13]	NASCIMBENI F, PAIS R, BELLENTANI S, et al. From NAFLD in clinical practice to answers from guidelines[J]. J Hepatol, 2013, 59(4): 859-871. DOI: 10.1016/j.jhep.2013.05.044.
[14]	ZHANG HJ, HE J, PAN LL, et al. Effects of moderate and vigorous exercise on nonalcoholic fatty liver disease: A randomized clinical trial[J]. JAMA Intern Med, 2016, 176(8): 1074-1082. DOI: 10.1001/jamainternmed.2016.3202.
[15]	VUPPALANCHI R, CHALASANI N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management[J]. Hepatology, 2009, 49(1): 306-317. DOI: 10.1002/hep.22603.
[16]	SUN GJ, JIANG AL, LI YB, et al. Progress in the research of metabonomics in disease diagnosis and Chinese medicine treatment [J]. Chin J Integr Trad West Med, 2021, 41(1): 122-125. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ202101030.htm 孙桂江, 姜埃利, 李遇伯, 等. 代谢组学在疾病诊断及中药治疗的研究进展[J]. 中国中西医结合杂志, 2021, 41(1): 122-125. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ202101030.htm
[17]	TIAN G, LI C, ZHAI YY, et al. Effect of Pudilan Xiaoyan Oral Liquid on energy metabolism in mice with acute pneumonia induced by LPS based on serum tar-geted metabolomics[J]. J Nangjing Univ Tradit Chin Med, 2021, 37(1): 120-125. DOI: 10.14148/j.issn.1672-0482.2021.0120. 田刚, 李超, 翟园园, 等. 基于血清靶向代谢组学研究蒲地蓝消炎口服液对脂多糖诱导的急性肺炎小鼠能量代谢的影响[J]. 南京中医药大学学报, 2021, 37(1): 120-125. DOI: 10.14148/j.issn.1672-0482.2021.0120.
[18]	MA R, XIE Q, WANG J, et al. Metabolomics study on effects of compatibility of alcohol extracts of Magnolia officinalis and Polygala tenuifolia on urine metabolites in rats[J]. Chin Pharmacol Bull, 2019, 35(6): 870-877. DOI: 10.3969/j.issn.1001-1978.2019.06.026. 马荣, 谢倩, 王建, 等. 基于代谢组学研究厚朴远志配伍醇提物对尿液代谢物的影响[J]. 中国药理学通报, 2019, 35(6): 870-877. DOI: 10.3969/j.issn.1001-1978.2019.06.026.
[19]	WANG X, WANG X, XIE G, et al. Urinary metabolite variation is associated with pathological progression of the post-hepatitis B cirrhosis patients[J]. J Proteome Res, 2012, 11(7): 3838-3847. DOI: 10.1021/pr300337s.
[20]	YU Y. The toxic effect of high dose phenylalanine on mice liver[D]. Changchun: Jilin University, 2018. 于杨. 高苯丙氨酸对小鼠肝脏的毒性作用[D]. 长春: 吉林大学, 2018.
[21]	SUN YX. Explore the protective mechanism of metformin on bisphenol A-induced liver injury in rats based on metabolomics[D]. Zhengzhou: Zhengzhou University, 2020. 孙亚新. 基于代谢组学技术的二甲双脈对双酚A诱导大鼠肝损伤的保护作用机制研究[D]. 郑州: 郑州大学, 2020.
[22]	WANG W, YANG J, QI W, et al. Lipidomic profiling of high-fat diet-induced obesity in mice: Importance of cytochrome P450-derived fatty acid epoxides[J]. Obesity (Silver Spring), 2017, 25(1): 132-140. DOI: 10.1002/oby.21692.
[23]	WATERS PJ, PARNIAK M, AKERMAN BR, et al. Characterization of phenylketonuria missense substitutions, distant from the phenylalanine hydroxylase active site, illustrates a paradigm for mechanism and potential modulation of phenotype[J]. Mol Genet Metab, 2000, 69(2): 101-110. DOI: 10.1006/mgme.2000.2965.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(4) / Tables(3)

Get Citation

PDF

XML

Article Metrics

Article views (581) PDF downloads(53)

A serum metabolomics study on the intervention of nonalcoholic fatty liver disease by equicaloric low-carbohydrate high-protein diet combined with aerobic exercise

DOI: 10.3969/j.issn.1001-5256.2021.11.023

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

A serum metabolomics study on the intervention of nonalcoholic fatty liver disease by equicaloric low-carbohydrate high-protein diet combined with aerobic exercise

DOI: 10.3969/j.issn.1001-5256.2021.11.023

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content